Zhang Yang, Zhao Meidan, Zhang Baozhen, Zhang Kai, Zhou Zhen
Rehabilitation Department, Tianjin Nankai Hospital, Tianjin, China.
Department of Acu-moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Front Neurol. 2021 Aug 26;12:711390. doi: 10.3389/fneur.2021.711390. eCollection 2021.
Acupuncture has been clinically used to treat epilepsy after stroke. However, most of the current clinical studies are observational studies, and there are few well-designed randomized controlled trials (RCTs). Hence, we designed a multicentre RCT to assess the advantages and efficacy of acupuncture for post-stroke epilepsy (PSE). This is a two-arm, parallel, participants-blinded and assessor-blinded and multicentre RCT. A total of 120 patients with PSE aged from 18 to 75 years will be randomly assigned to two groups (routine treatment plus acupuncture group and routine treatment plus sham acupuncture group) at a 1:1 ratio. The participants will perform acupuncture or sham acupuncture treatment three times a week and be ongoing 8-week treatment. The primary endpoint is the proportion of seizure-free patients. A safety profile will be established. We will record adverse events for the safety evaluation. The study will provide high-quality clinical evidence on the effectiveness and safety of acupuncture for treating patients with epilepsy after stroke. Chinese Clinical Trial Registry, identifier: ChiCTR2100046114.
针刺已被临床用于治疗中风后癫痫。然而,目前大多数临床研究都是观察性研究,设计良好的随机对照试验(RCT)较少。因此,我们设计了一项多中心RCT,以评估针刺治疗中风后癫痫(PSE)的优势和疗效。这是一项双臂、平行、参与者和评估者双盲的多中心RCT。共有120例年龄在18至75岁之间的PSE患者将以1:1的比例随机分为两组(常规治疗加针刺组和常规治疗加假针刺组)。参与者将每周进行3次针刺或假针刺治疗,持续8周。主要终点是无癫痫发作患者的比例。将建立安全性概况。我们将记录不良事件以进行安全性评估。该研究将为针刺治疗中风后癫痫患者的有效性和安全性提供高质量的临床证据。中国临床试验注册中心,标识符:ChiCTR2100046114。